Skip to main content

Siolta Therapeutics

San Carlos, United States

Siolta Therapeutics is a biotech company focused on developing therapeutic microbial consortia to prevent and treat inflammatory diseases.

$12.0M raised
Mar 2024
Series C

Top Investors

Khosla VenturesGlobal Brain CorporationSeventure PartnersTime VenturesNational Institute of Allergy and Infectious Diseases

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Siolta Therapeutics

How much funding has Siolta Therapeutics raised?
Siolta Therapeutics has raised $12.0M in total funding. The most recent round was Series C. The last funding was announced in March 2024.
Who are Siolta Therapeutics's investors?
Siolta Therapeutics's investors include Khosla Ventures, Global Brain Corporation, Seventure Partners, Time Ventures, National Institute of Allergy and Infectious Diseases.
Where is Siolta Therapeutics headquartered?
Siolta Therapeutics is headquartered in San Carlos, United States.
What does Siolta Therapeutics do?
Siolta Therapeutics is a biotech company focused on developing therapeutic microbial consortia to prevent and treat inflammatory diseases.
What stage is Siolta Therapeutics at?
Siolta Therapeutics is at the Series C stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Siolta Therapeutics — Funding & Investors." VCBacked, March 12, 2024, https://www.vcbacked.co/company/siolta-therapeutics. Accessed June 4, 2026.
APA
VCBacked. (2024). Siolta Therapeutics — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/siolta-therapeutics
Wikipedia (cite web)
{{cite web |title=Siolta Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/siolta-therapeutics |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .